Age-related macular degeneration (AMD) is the leading cause of legal blindness in the
industrialized world. AMD is characterized by accumulation of extracellular deposits, namely …

Purpose To estimate rates and risk factors for progression to geographic atrophy (GA) or
choroidal neovascularization (CNV) among eyes diagnosed with early or intermediate age …

Purpose Age-related macular degeneration (AMD) is a leading cause of blindness,
particularly in higher-income countries. Although dry AMD accounts for 85% to 90% of AMD …

Among older adults, age-related macular degeneration (AMD) is a prevalent disabling
condition that begins as subtle visual disturbances and can progress to permanent loss of …

Age-related diseases, including age-related macular degeneration (AMD), are of growing
importance in a world where population ageing has become a dominant global trend …

Purpose To investigate associations of adherence to the Mediterranean diet (MeDi) with
incidence of advanced age-related macular degeneration (AMD; the symptomatic form of …

Age-related macular degeneration (AMD) is a degenerative disease of the human retina
affecting individuals over the age of 55 years. This heterogeneous condition arises from a …

Age-related macular degeneration (AMD) is the leading cause of severe irreversible central
vision loss in individuals over 65 years old. Genome-wide association studies (GWASs) …

Purpose Age-related macular degeneration (AMD) is a common multifactorial disease in the
elderly with a prominent genetic basis. Many risk variants have been identified, but the …

Purpose: To assess the gap between visual acuity (VA) outcomes with anti-vascular
endothelial growth factor (anti-VEGF) therapies in clinical trials and real-world practice, and …